Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel vs Clopidogrel Platelet Inhibition Post-Bivalirudin in PCI
NCT01789814Phase 4Completed
- Sponsor
- Tufts Medical Center
- Start
- Jul 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of prasugrel in coronary artery disease (CAD) (2 arms), sponsored by Tufts Medical Center. Primary endpoint: Change From Baseline in ADP-mediated Platelet Aggregation. Started Jul 2013; status: completed.
02
Drugs
prasugrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01789814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01789814.